Nuvectis Pharma, Inc. Common Stock

NVCTNASDAQUSD
27.19 USD
0.68 (2.44%)AT CLOSE (11:59 AM EDT)
27.21
0.02 (0.07%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
27.21
0.02 (0.07%)
🔴Market: CLOSED

Shares of Nuvectis Pharma, Inc. Common Stock (NVCT) are trading at $27.19. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, NVCT is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 26, 2026.

Open?$27.85
High?$28.37
Low?$23.71
Prev. Close?$27.87
Volume?1.3M
Avg. Volume?226.8K
VWAP?$25.79
Rel. Volume?5.63x
Bid / Ask
Bid?$22.47 × 100
Ask?$33.04 × 100
Spread?$10.57
Midpoint?$27.76
Valuation & Ratios
Market Cap?721.2M
Shares Out?26.5M
Float?15.5M
Float %?58.4%
P/E Ratio?N/A
P/B Ratio?50.72
EPS?-$1.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Employees
13
Market Cap
739.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-02-04
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Phone: 360-837-7232
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?29.88Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.14%High
Short Interest?1.6M
Days to Cover?22.6
Free Float15.5M
Avg Daily Volume69.3K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.27Strong
Quick Ratio?2.27Strong
Cash Ratio?2.25Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
3
50.72HIGH
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-24.6CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-208.1%WEAK
ROA?
S&P
3
-116.5%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$696.1M
Fundamentals ratios updated end of day